These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1934525)

  • 1. Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle.
    Burger HG; Kovacs GT; Polson DM; McDonald J; McCloud PI; Harrop M; Colman P; Healy DL
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):119-22. PubMed ID: 1934525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders.
    Levy T; Limor R; Villa Y; Eshel A; Eckstein N; Vagman I; Lidor A; Ayalon D
    Hum Reprod; 1993 Jun; 8(6):834-9. PubMed ID: 8345071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue.
    Vegetti W; Testa G; Ragni G; Parazzini F; Crosignani PG
    Gynecol Obstet Invest; 1998; 45(3):186-9. PubMed ID: 9565144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.
    Homburg R; Orvieto R; Bar-Hava I; Ben-Rafael Z
    Hum Reprod; 1996 Apr; 11(4):716-9. PubMed ID: 8671313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3).
    Huang ZH; Baxter RC; Hughes SM; Matson PL; Lieberman BA; Morris ID
    Hum Reprod; 1993 Jun; 8(6):850-7. PubMed ID: 7688379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial.
    Homburg R; West C; Torresani T; Jacobs HS
    Fertil Steril; 1990 Feb; 53(2):254-60. PubMed ID: 2105243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualised gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: A prospective, observational study.
    Lauritsen MP; Loft A; Pinborg A; la Cour Freiesleben N; Cohen A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():76-82. PubMed ID: 27960134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone?
    Jacobs HS
    Horm Res; 1992; 38 Suppl 1():14-21. PubMed ID: 1295808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.
    van Santbrink EJ; Donderwinkel PF; van Dessel TJ; Fauser BC
    Hum Reprod; 1995 May; 10(5):1048-53. PubMed ID: 7657739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
    Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
    Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
    Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovulation induction in anovulatory women].
    La Marca A; Bertucci E; Giulini S; Tirelli A; Malavasi B; Volpe A
    Minerva Ginecol; 2006 Dec; 58(6):489-97. PubMed ID: 17108879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.